Standard BioTools | 4: Statement of changes in beneficial ownership of securities-Officer Black Jeffrey G.
Standard BioTools | PREC14A: Others
Standard BioTools | 10-Q: Quarterly report
Standard BioTools | 8-K: Standard BioTools Reports First Quarter 2024 Financial Results
Standard BioTools | 10-K/A: Annual report (Amendment)
Standard BioTools | 8-K: Current report
Standard BioTools | 4: Statement of changes in beneficial ownership of securities-Officer Egholm Michael
Standard BioTools | 4: Statement of changes in beneficial ownership of securities-Officer Egholm Michael
Standard BioTools | 4: Statement of changes in beneficial ownership of securities-Officer Kim Hanjoon Alex
Standard BioTools | 144: Notice of proposed sale of securities pursuant to Rule 144
Standard BioTools | 144: Notice of proposed sale of securities pursuant to Rule 144
Standard BioTools | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Viking Global Investors LP(15.3%),Viking Global Opportunities Parent GP LLC(15.3%), etc.
Standard BioTools | 3: Initial statement of beneficial ownership of securities-10% Owner VIKING GLOBAL INVESTORS LP
Standard BioTools | 4: Statement of changes in beneficial ownership of securities-Director Casdin Partners Master Fund, L.P.
Standard BioTools | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Eli Casdin(19.25%),Casdin Capital, LLC(16.19%), etc.
Standard BioTools | 144: Notice of proposed sale of securities pursuant to Rule 144
Standard BioTools | 144: Notice of proposed sale of securities pursuant to Rule 144
Standard BioTools | 8-K: Current report
Standard BioTools | 144: Notice of proposed sale of securities pursuant to Rule 144
Standard BioTools | 4: Statement of changes in beneficial ownership of securities-Director Casdin Partners Master Fund, L.P.
No Data